Precursor of N-acetylgalactosamine-4-sufatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

The present invention provides a highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase and biologically active mutants, fragments and analogs thereof as well as pharmaceutical formulations comprising highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatas...

Full description

Saved in:
Bibliographic Details
Main Authors Qin, Minmin, Zecherle, Gary, Chan, Wai-Pan, Fitzpatrick, Paul, Sweidler, Stuart, Henstrand, John, Wendt, Dan, Chen, Lin, Starr, Christopher
Format Patent
LanguageEnglish
Published 08.07.2004
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase and biologically active mutants, fragments and analogs thereof as well as pharmaceutical formulations comprising highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase. The invention also provides methods for treating diseases caused all or in part by deficiencies in human N-acetylgalactosamine-4-sulfatase including MPS VI and methods for producing and purifying the recombinant precursor enzyme to a highly purified form.